Pacific Sage Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
686
-89
-11% -$42.7K 0.05% 88
2026
Q1
$381K Hold
775
0.06% 77
2025
Q4
$449K Buy
775
+16
+2% +$9.05K 0.07% 73
2025
Q3
$368K Sell
759
-1
-0.1% -$465 0.06% 77
2025
Q2
$308K Buy
760
+7
+0.9% +$2.93K 0.06% 80
2025
Q1
$375K Hold
753
0.08% 70
2024
Q4
$392K Hold
753
0.09% 64
2024
Q3
$466K Sell
753
-1
-0.1% -$592 0.11% 58
2024
Q2
$417K Buy
754
+3
+0.4% +$1.72K 0.1% 62
2024
Q1
$436K Hold
751
0.11% 57
2023
Q4
$399K Hold
751
0.11% 58
2023
Q3
$380K Hold
751
0.11% 54
2023
Q2
$392K Hold
751
0.12% 52
2023
Q1
$433K Sell
751
-69
-8% -$38.9K 0.14% 46
2022
Q4
$452K Buy
+820
New +$435K 0.15% 44

Other funds holding TMO

Pacific Sage Partners's TMO Position: Q2 2026 in Review

Pacific Sage Partners reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $42.7K and leaving 686 shares worth $344K. The position accounts for 0.05% of the portfolio, ranked #88.

Pacific Sage Partners first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $466K in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pacific Sage Partners held 686 shares of Thermo Fisher Scientific worth $344K as of Q2 2026.
  • Pacific Sage Partners sold 89 Thermo Fisher Scientific shares in Q2 2026, an estimated $42.7K.
  • Thermo Fisher Scientific made up 0.05% of Pacific Sage Partners's portfolio in Q2 2026, its #88 holding.
  • Pacific Sage Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Pacific Sage Partners's Thermo Fisher Scientific position peaked at $466K in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pacific Sage Partners's 13F filing for Q2 2026, filed 6 Aug 2026.